Complete amenorrhea following NovaSure endometrial ablation for resistant menorrhagia: a case report

Abstract

Heavy menstrual bleeding (HMB) or menorrhagia is the most common form of dysfunctional uterine bleeding (DUB). In spite of medical treatment for DUB, many women will eventually require a hysterectomy, which is an invasive treatment option. NovaSure ablation offers a same day non-invasive alternative to hysterectomy and hysteroscopic ablation. A 38-year-old woman presented with HMB in 2015. The attacks of HMB interrupted her lifestyle, and she refused to continue with medical treatment, which failed to resolve her symptoms. This patient was admitted to the hospital four times over 2015 due to the anemia caused by the DUB. Medroxyprogesterone acetate and oral contraceptive pills failed to control the patient’s bleeding episodes. Hysteroscopic examination of the uterine cavity showed a normal cavity, and the endometrial biopsy showed proliferative endometrium. She was counseled about NovaSure ablation as the last treatment option before hysterectomy. The NovaSure ablation procedure took 90 s, and the patient was discharged from the hospital 6 h after the procedure. At follow-up, the patient is completely amenorrheic, and she is satisfied with her results. This study demonstrated that NovaSure endometrial ablation is a safe, effective, non-invasive alternative to hysteroscopic endometrial ablation for treatment of DUB.

Keywords

Amenorrhea / NovaSure / ablation / menorrhagia

References

[1] Abdelazim IA,Hamdan SB.Outcome and hemodynamic alternation in uterine artery following hysteroscopic roller-ball endometrial ablation..J Gynecol Res2015;1:105

[2] Abdelazim IA.Outcome and uterine arteries Doppler velocimetry after thermal balloon endometrial ablation in menorrhagia..Evid Based Women Health J2013;3:35-8

[3] Lethaby A,Garry R.Endometrial destruction techniques for heavy menstrual bleeding..Cochrane Database Syst Rev2009;(4):CD001501

[4] Garside R,Wyatt K,Price A.The effectiveness and cost-effectiveness of microwave and thermal balloon endometrial ablation for heavy menstrual bleeding: a systematic review and economic modelling..Health Technol Assess2004;8:1-155

[5] Abbott JS.The surgical management of menorrhagia..Hum Reprod Update2002;8:68-78

[6] Wellington K.Tranexamic acid: a review of its use in the management of menorrhagia..Drugs2003;63:1417-33

[7] Practice Committee of American Society for Reproductive Medicine. Indications and options for endometrial ablation..Fertil Steril2008;90:S236-40

[8] Gimpelson RJ.Ten-year literature review of global endometrial ablation with the NovaSure? device..Int J Womens Health2014;6:269-80 PMCID:PMC3956630

[9] Gallinat A.NovaSure impedance-controlled system for endometrial ablation: three-year follow-up on 107 patients..Am J Obstet Gynecol2004;191:1585-9

[10] Gallinat A.NovaSure impedance-controlled system for endometrial ablation..J Am Assoc Gynecol Laparosc2002;9:283-9

[11] Kalkat RK.NovaSure endometrial ablation under local anaesthesia in an outpatient setting: An observational study..J Obstet Gynecol2011;31:152-5

[12] Thiel JA,Pohlman S.Evaluation of the NovaSure endometrial ablation procedure in women with uterine cavity length over 10 cm..J Obstet Gynaecol Can2014;36:491-4

[13] Clark TJ,Malick S,Daniels J.Bipolar radiofrequency compared with thermal balloon endometrial ablation in the office: a randomized controlled trial..Obstet Gynecol2011;117:1228

[14] Abbott J,Hunter D.A double blind randomized trial comparing the Cavaterm and the NovaSure endometrial ablation systems for the treatment of dysfunctional uterine bleeding..Fertil Steril2003;80:203-8